Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 75 references it cites were found in a registry or an index; 15 of the 87 sources its claims cite were checked for support.

Analysis of the efficacy, safety, and regulatory status of novel forms of creatine

Open access

Abstract

Creatine has become one of the most popular dietary supplements in the sports nutrition market. The form of creatine that has been most extensively studied and commonly used in dietary supplements is creatine monohydrate (CM). Studies have consistently indicated that CM supplementation increases muscle creatine and phosphocreatine concentrations by approximately 15-40%, enhances anaerobic exercise capacity, and increases training volume leading to greater gains in strength, power, and muscle mass. A number of potential therapeutic benefits have also been suggested in various clinical populations. Studies have indicated that CM is not degraded during normal digestion and that nearly 99% of orally ingested CM is either taken up by muscle or excreted in urine. Further, no medically significant side effects have been reported in literature. Nevertheless, supplement manufacturers have continually introduced newer forms of creatine into the marketplace. These newer forms have been purported to have better physical and chemical properties, bioavailability, efficacy, and/or safety profiles than CM. However, there is little to no evidence that any of the newer forms of creatine are more effective and/or safer than CM whether ingested alone and/or in combination with other nutrients. In addition, whereas the safety, efficacy, and regulatory status of CM is clearly defined in almost all global markets; the safety, efficacy, and regulatory status of other forms of creatine present in today's marketplace as a dietary or food supplement is less clear.

Overview

CoChat Summary

TL;DR

This review compares creatine monohydrate (CM) with newer creatine forms and concludes that CM is the most studied, effective, and stable form, with no medically significant side effects reported, while newer forms lack evidence of superior efficacy or safety. It also finds that most alternative creatine forms have unclear or unauthorized regulatory status in major markets.

Key findings

  • CM supplementation consistently increases muscle creatine/phosphocreatine by approximately 15–40%, enhances anaerobic exercise capacity, and increases training volume leading to greater gains in strength, power, and muscle mass; nearly 99% of orally ingested CM is either taken up by muscle or excreted in urine, and no medically significant side effects have been reported.
  • Newer forms generally contain less creatine than CM (CM 87.9%; creatine ethyl ester 82.4%; creatine citrate 66%; creatine pyruvate 60%; creatine anhydrous 100%), and some are less stable: tricreatine citrate showed creatinine levels of 770 ppm at 40°C after 28 days, whereas CM showed no degradation at 40°C for more than 3 years (creatinine under 67 ppm) and only 106 ppm at 60°C after 44 months.
  • Bioavailability/ergogenic comparisons were mixed: creatine pyruvate had 17% higher mean peak and 14% higher AUC plasma creatine than CM in six subjects; whole-body creatine retention was 61 ± 15% for CM, 80 ± 11% for CM plus dextrose, and 63 ± 13% for effervescent tricreatine citrate (no significant CM vs. tricreatine citrate difference); liquid creatine had no effect on muscle phosphagen levels, while CM increased muscle free creatine by 31 ± 28%; creatine ethyl ester increased serum creatinine and raised muscle total creatine less than CM.
  • Regulatory status: CM is approved or grandfathered in the USA, Canada, EU, Japan, South Korea, and Brazil; Japan also approved creatine citrate and creatine pyruvate for import; the FDA objected to creatine ethyl ester, creatine-L-carnitinate, and tricreatine orotate, with no decision posted for creatine pyruvate; no other forms were approved in Canada, EU, South Korea, or Brazil.

Methods

  • Systematic review of literature on creatine forms available globally as dietary supplements, food supplements, or natural health products; Medline searches used creatine search terms plus technical/performance aspects (e.g., solubility, stability, bioavailability, performance), along with patent searches of WIPO, the European Patent Office, the Japan Patent Office, and the United States Patent and Trademark Office.
  • Regulatory assessment accessed websites of the US FDA, Health Canada, European Commission, Japan Ministry of Health, Labor and Welfare, and Korea Food and Drug Administration; Brazil’s ANVISA is also discussed in the regulatory section.

Limitations

  • Stated in the paper: there is little to no evidence that newer forms are more effective or safer than CM; basic safety data on new forms are lacking; public health implications of unsanctioned forms are unknown; more research is needed (e.g., for d-pinitol, Russian tarragon, and creatine pyruvate); and some regulatory decisions may be pending.
  • Evident from the text: several included studies are small (e.g., six subjects in the plasma kinetics study; 16 males in the retention study; 24–30 participants in training studies), some comparisons lack head-to-head CM controls (e.g., creatine citrate studies did not compare to CM), and the review does not describe formal inclusion/exclusion criteria, risk-of-bias assessment, or quantitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00726-011-0874-6

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Creatine salts
Fig. 1 Creatine saltsCC BY-NC · PubMed Central
Fig. 2 Chemical structure of creatine and creatine derivatives
Fig. 2 Chemical structure of creatine and creatine derivativesCC BY-NC · PubMed Central
Fig. 3 Stability of creatine monohydrate powder. Adapted from Jäger (2003)
Fig. 3 Stability of creatine monohydrate powder. Adapted from Jäger (2003)CC BY-NC · PubMed Central
Fig. 4 Degradation of creatine to creatinine
Fig. 4 Degradation of creatine to creatinineCC BY-NC · PubMed Central
Fig. 5 Effect of pH on creatine stability in solution. Adapted from Howard and Harris (1999)
Fig. 5 Effect of pH on creatine stability in solution. Adapted from Howard and Harris (1999)CC BY-NC · PubMed Central
Fig. 6 Very low pH prevents creatine degradation
Fig. 6 Very low pH prevents creatine degradationCC BY-NC · PubMed Central
Fig. 7 Degradation of creatine and creatine ester
Fig. 7 Degradation of creatine and creatine esterCC BY-NC · PubMed Central
Fig. 8 Comparison of blood plasma levels of different forms of creatine. Adapted from Jäger et al. (2007)
Fig. 8 Comparison of blood plasma levels of different forms of creatine. Adapted from Jäger et al. (2007)CC BY-NC · PubMed Central
Fig. 9 Percentage of creatine retained during a 3-day loading period (20 g/day). Adapted from Greenwood et al. (2003)
Fig. 9 Percentage of creatine retained during a 3-day loading period (20 g/day). Adapted from Greenwood et al. (2003)CC BY-NC · PubMed Central
Fig. 10 Change in muscle-free creatine content in response to 5 days of low or high-dose creatine serum and placebo ingestion compared to CM. Adapted from Kreider et al. (2003b)
Fig. 10 Change in muscle-free creatine content in response to 5 days of low or high-dose creatine serum and placebo ingestion compared to CM. Adapted from Kreider et al. (2003b)CC BY-NC · PubMed Central
Fig. 11 Changes in total muscle creatine content in response to placebo (PLA), creatine monohydrate (CRT), and creatine ethyl ester (CEE) supplementation (Spillane et al. 2009). †Significantly different from PLA group. *Significant difference from baseline. Reprinted with permission
Fig. 11 Changes in total muscle creatine content in response to placebo (PLA), creatine monohydrate (CRT), and creatine ethyl ester (CEE) supplementation (Spillane et al. 2009). †Significantly different from PLA group. *Significant difference from baseline. Reprinted with permissionCC BY-NC · PubMed Central
Fig. 12 Change in whole body creatine retention in response to 5 days of placebo, creatine monohydrate (CM), low-dose d-pinitol (P) and CM, and high-dose P and CM supplementation. Adapted from Kerksick et al. (2007)
Fig. 12 Change in whole body creatine retention in response to 5 days of placebo, creatine monohydrate (CM), low-dose d-pinitol (P) and CM, and high-dose P and CM supplementation. Adapted from Kerksick et al. (2007)CC BY-NC · PubMed Central
Fig. 13 Influence of Russian tarragon on creatine absorption. Adapted from Jäger et al. (2008a)
Fig. 13 Influence of Russian tarragon on creatine absorption. Adapted from Jäger et al. (2008a)CC BY-NC · PubMed Central

Verification

Claims the paper makes

13 Valid · 6 Not valid · 54 Not checked · 87 Own results and interpretations

81 more claims · 4 with their cited sources checked

Create a free account to see all 160 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 60
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

37 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 75 references

Research works printed but not linked: 7

  1. Greenhaff P (1997a) Creatine supplementation and implications for exercise performance. In: Jeudendrup A, Brouns M, Brouns F (eds) Advances in training and nutrition for endurance sports. Novartis Nutrition Research Unit, Maasticht
  2. Greenhaff P, Bodin K, Harris R, Hultman E, Jones DG, McIntyre D, Soderlund K, Turner DL (1993) The influence of oral creatine supplementation on muscle phosphocreatine resynthesis following intense contraction in man. J Physiol 467:75P
  3. Harris RC, Soderlund K, Hultman E (1992b) Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond) 83(3):367–374 · DOI · Paper page
  4. Kreider RB, Klesges RC, Lotz D, Davis M, Cantler E, Harmon-Clayton K, Dudley R, Grindstaff P, Ramsey L, Bullen D, Wood L, Almada A (1999) Effects of nutritional supplementation during off-season college football training on body composition and strength. J Exerc Physiol online 2(2):24–39
  5. Kreider RB, Willoughby DS, Greenwood M, Parise G, Payne E, Tarnopolsky MA (2003b) Effects of serum creatine supplementation on muscle creatine content. J Exerc Physiol online 6(4):24–33
  6. NBJ (2009) Sports nutrition & weight loss report. Nutrition Business Journal, vol XIV, September edn., Boulder
  7. Shimizu T (2008) Korean latest conditions of health food labeling. Food Style 12(1):54–56

Cited by

See all 189

Metadata

Authors
Jäger, R., Purpura, M., Shao, A., Inoue, T., & Kreider, R. B.
Affiliations
  • Increnovo LLC (United States) (US)
  • Texas A&M University (US)
Corresponding author
Kreider, Richard B.
Venue
Amino Acids
Published
2011-03-22
Volume
40
Issue
5
Pages
1369-1383
ISSN
  • 0939-4451 (ISSN-L)
  • 1438-2199
OpenAlex
W2137242866
Cited by
181
References
75
Citations by year
2026: 16 · 2025: 18 · 2024: 22 · 2023: 13 · 2022: 19 · 2021: 16 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 5 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 6 · 2012: 5
FWCI
0.63
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Amino Acids (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
Keywords
creatine, creatine monohydrate, sports nutrition, dietary supplements, bioavailability, supplement efficacy, supplement safety, regulatory status, phosphocreatine, muscle creatine, anaerobic exercise performance, muscle mass
MeSH terms
Creatine, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-31, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-31 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. https://app.cochat.ai/papers/10.1007/s00726-011-0874-6
The paper
Jäger, R., Purpura, M., Shao, A., Inoue, T., & Kreider, R. B. (2011). Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. https://doi.org/10.1007/s00726-011-0874-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.